Scotland Approves New Menopause Drug for 48,000 Women

Women across Scotland are celebrating access to a game-changing menopause treatment that offers hope where options were once limited.

NHS Scotland has approved fezolinetant (brand name Veoza) for women who cannot take traditional hormone replacement therapy. The Scottish Medicines Consortium green-lit the drug after clinical trials proved it can reduce both the frequency and severity of hot flushes and night sweats.

Unlike HRT, which replaces hormones, this medication works by blocking a specific neurotransmitter in the brain that triggers hot flushes. That targeted approach means women with health conditions that prevent them from taking hormones finally have an alternative.

The numbers tell the story of how many lives this could change. About 400,000 women in Scotland are currently menopausal, and drug manufacturer Astellas Pharma estimates up to 48,000 could benefit from this treatment.

Dr. Kay McAllister, a consultant gynaecologist who leads menopause services at NHS Glasgow and Greater Clyde, sees the real-world impact daily. "In clinical practice, I see how hot flushes and night sweats impact sleep and overall quality of life in my patients," she said.

For women who have endured years of disrupted sleep, embarrassing public hot flushes, and the exhaustion that comes with both, this approval represents more than just another medication option. It's validation that their suffering matters and deserves targeted solutions.

The Ripple Effect

The approval in Scotland could pave the way for broader access across the UK and signal to other health systems that investing in menopause care pays dividends. When women get effective treatment, they sleep better, work more productively, and enjoy fuller lives with their families and communities.

Dr. Rob Peel, who chairs the Scottish Medicines Consortium, emphasized that quality of life matters. "For those who cannot take HRT, effective treatment options are limited," he noted, adding that he knows this decision will be welcomed.

The drug offers something medicine doesn't always provide: personalized care that acknowledges not every treatment works for every body.

Thousands of Scottish women can now look forward to cooler nights and calmer days ahead.